Literature DB >> 16679745

Effect of Lycium barbarum polysaccharide on the improvement of antioxidant ability and DNA damage in NIDDM rats.

Hao Wu1, Hongwei Guo, Rui Zhao.   

Abstract

The effects of polysaccharide extracted from Lycium barbarum (LBP) on blood glucose, oxidative stress and DNA damage in rats with non-insulin dependent diabetes mellitus (NIDDM) were studied. The results show that LBP treatment (10 mg/kg.d) for 4 weeks led to decreased levels of blood glucose, malondialdehyde (MDA) and nitric oxide (NO) in serum of fasting rats; and to increased serum level of superoxidedismutase (SOD). Furthermore, LBP could reduce cellular DNA damage in peripheral lymphocytes of NIDDM rats. The DNA damage was determined by using the single cell gel (comet) assay with alkaline electrophoresis and was quantified by measuring tail length and tail moment. These results suggest that LBP can control blood glucose and modulate the metabolism of glucose, leading to significant improvement of oxidative stress markers (SOD, MDA) in rats with NIDDM. And that, LBP decreases DNA damage possibly via a decrease in oxidative stress levels. In conclusion, LBP as a dietary supplement may prevent the development of complications or even tendency to carcinogenesis in NIDDM rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679745     DOI: 10.1248/yakushi.126.365

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  20 in total

Review 1.  Integrative oncology meets immunotherapy: new prospects for combination therapy grounded in Eastern medical knowledge.

Authors:  Gerard Bodeker
Journal:  Chin J Integr Med       Date:  2012-08-31       Impact factor: 1.978

Review 2.  Antidiabetic plant-derived nutraceuticals: a critical review.

Authors:  Jayapal Naveen; Vallikannan Baskaran
Journal:  Eur J Nutr       Date:  2017-10-11       Impact factor: 5.614

3.  Exotic Fruits as Therapeutic Complements for Diabetes, Obesity and Metabolic Syndrome.

Authors:  Samir Devalaraja; Shalini Jain; Hariom Yadav
Journal:  Food Res Int       Date:  2011-08-01       Impact factor: 6.475

Review 4.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

Review 5.  Cardiovascular disease risk reduction with wolfberry consumption: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Darel Wee Kiat Toh; Jasmine Hui Min Low; Jung Eun Kim
Journal:  Eur J Nutr       Date:  2021-11-27       Impact factor: 5.614

Review 6.  Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far?

Authors:  Raymond Chuen-Chung Chang; Kwok-Fai So
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

Review 7.  Phytotherapy in diabetes: Review on potential mechanistic perspectives.

Authors:  Hanan S El-Abhar; Mona F Schaalan
Journal:  World J Diabetes       Date:  2014-04-15

8.  Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest.

Authors:  Fang Mao; Bingxiu Xiao; Zhen Jiang; Junwei Zhao; Xia Huang; Junming Guo
Journal:  Med Oncol       Date:  2010-01-12       Impact factor: 3.064

9.  Delayed growth of glioma by a polysaccharide from Aster tataricus involve upregulation of Bax/Bcl-2 ratio, activation of caspase-3/8/9, and downregulation of the Akt.

Authors:  Lei Du; Hai-Feng Mei; Xue Yin; Yi-Qiao Xing
Journal:  Tumour Biol       Date:  2013-10-01

10.  Effect of Shilianhua extract and its fractions on body weight of obese mice.

Authors:  Jun Yin; Aamir Zuberi; Zhanguo Gao; Dong Liu; Zhijun Liu; William T Cefalu; Jianping Ye
Journal:  Metabolism       Date:  2008-07       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.